Project Grant R21ES039043
- The National Institute of Environmental Health Sciences awarded Trustees of Boston University $100,228 on December 28, 2026, under the Environmental Health program (CFDA 93.113) to conduct epidemiological research on persistent endocrine-disrupting chemical mixtures and maternal-infant health outcomes. Principal Investigator Noelle Henderson will quantify the impact of pre-conception maternal exposure to polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and organochlorine...
- The National Institute of Environmental Health Sciences awarded Boston University Medical Campus $197,600 on November 1, 2025, under the Environmental Health program (CFDA 93.113) to examine early-life exposure to ferroalloy metal mixtures and adolescent cognition. The research investigates how exposure to neuroactive metals—manganese, lead, chromium, and copper—released through ferroalloy industrial emissions affects neurodevelopment in children and adolescents living near such facilities....
- The National Institute of Environmental Health Sciences awarded the University of Massachusetts $752,690 on August 13, 2026, for research on preconception and early pregnancy exposure to endocrine-disrupting chemicals under the Environmental Health grant program (CFDA 93.113). The project investigates how exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS), polybrominated diphenyl ethers (PBDEs), and trace elements affects women's reproductive health and the ability to achieve...
- The National Institute of Environmental Health Sciences awarded $722,000 to the President and Fellows of Harvard College (Harvard T.H. Chan School of Public Health) on August 26, 2026, under the Environmental Health program (CFDA 93.113) to develop an integrated molecular exposomics platform mapping how environmental chemicals move from blood to tissues and alter cellular function. The project establishes three synergistic modules. Module 1 creates comprehensive blood exposomics using...
- The National Institute of Environmental Health Sciences awarded Baylor College of Medicine $639,797 on April 1, 2026, under the Environmental Health program (CFDA 93.113) to characterize the association between micro- and nanoplastic particle (MNP) exposure and preterm birth and to map the inflammatory and immunological mechanisms by which placental exposure to MNP drives adverse pregnancy outcomes. The research quantifies temporal patterns of MNP accumulation across 3,500 biospecimens (maternal...
- This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $419,011 to Emory University to develop innovative dimensionality reduction techniques for assessing the joint health effects of air pollution mixtures. The research aims to advance causal modeling approaches that preserve the relationships between air pollutants and health outcomes, in order to provide more accurate assessments of the public...
- The National Institute of Environmental Health Sciences, a component of the Department of Health and Human Services, awarded The General Hospital Corporation (Massachusetts General Hospital) $376,238 on September 23, 2025, under the Environmental Health program (CFDA 93.113, Program Grant R21ES036753). The project, titled "Air Pollution and Well-Being: Assessing Risks and Enhancing Education in Uganda (AWARE Study)," characterizes local knowledge, attitudes, and perceptions about air...
- The National Institute of Environmental Health Sciences, a component of the Department of Health and Human Services National Institutes of Health, awarded the University of Texas at Austin $415,906 on June 1, 2026, under the Environmental Health program (CFDA 93.113) to investigate how air pollution induces shifts in the RNA modification landscape and how pseudouridine-incorporating enzymes relocalize in response to airborne toxins. The research examines whether exposure to ambient air pollution...
- The National Institute of Environmental Health Sciences, part of the Department of Health and Human Services, awarded Research Triangle Institute (RTI International) $221,941 under the Environmental Health program (CFDA 93.113) on June 1, 2026. The project, titled "Enhancing Personal Air Pollution Exposure Data for Mechanistic Health Research," addresses limitations in conventional exposure assessments of fine particulate matter (PM2.5). Current mass-based metrics fail to capture...
- The National Institute of Environmental Health Sciences, a division of the Department of Health and Human Services, awarded Uv01 Technologies, Inc. $306,548 under the Environmental Health program (CFDA 93.113) on August 1, 2026, to develop CLYR-VUE, an artificial intelligence and machine learning-powered just-in-time adaptive intervention that addresses indoor air pollution exposure in residential homes. The recipient will develop hardware and software infrastructure incorporating...
The National Institute of Environmental Health Sciences awarded the Trustees of Boston University $245,250 on August 13, 2026, under the Environmental Health program (CFDA 93.113) to develop and pilot an integrated air pollution exposure assessment framework for reproductive health research. The project combines real-time residential indoor monitoring with residence-level outdoor pollution models and weekly time-activity data collected across preconception and gestational periods. Aim 1 deploys low-cost monitors to 140 participants in geographically diverse homes to characterize weekly indoor concentrations of particulate matter (PM2.5 primary; PM10, NO2/NOx, VOCs, temperature, and humidity secondary) and identify modifiable and non-modifiable determinants. Aim 2 builds predictive indoor models incorporating outdoor concentrations, weekly pollution sources, time-activity patterns, meteorology, and housing features; applies population-average predictions cohort-wide; and computes integrated, time-weighted exposure metrics. The work leverages PRESTO, a nationwide preconception cohort of over 20,500 U.S. participants with broad geographic coverage and proven capacity for participant-operated monitoring. Boston University Medical Campus serves as the recipient, with place of performance at Roxbury, Massachusetts. The project period extends from the award date through July 31, 2028. This assistance type is classified as a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $245.3k | 8/13/26 |